ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 1942

$554K Total Retail Price of All Prescriptions

Rank: 56 out of 1942

587 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 587 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,603 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 496 443 1 1
LISINOPRIL 432 393 2 2
ATENOLOL 412 386 3 7
LEVOTHYROXINE SODIUM 358 286 4 3
HYDROCODONE-ACETAMINOPHEN 302 238 S3 5 12
OMEPRAZOLE 271 221 6 4
AMLODIPINE BESYLATE 259 245 7 6
LOVASTATIN 236 183 8 32
LOSARTAN POTASSIUM 226 221 9 18
ATORVASTATIN CALCIUM 225 194 10 14
WARFARIN SODIUM 219 193 11 11
CRESTOR 183 159 12 34
GABAPENTIN 178 145 13 16
METFORMIN HCL 175 150 14 10
METOPROLOL TARTRATE 153 137 15 9
HYDROCHLOROTHIAZIDE 151 144 16 8
CITALOPRAM HBR 148 121 17 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 126 18 22
FUROSEMIDE 138 109 19 5
ZOLPIDEM TARTRATE 137 106 20 25
METOPROLOL SUCCINATE 136 109 21 13
OXYCODONE-ACETAMINOPHEN 132 53 S2 22 56
TRAZODONE HCL 128 104 23 24
PANTOPRAZOLE SODIUM 128 84 23 48
TRAMADOL HCL 124 94 25 19
ALENDRONATE SODIUM 123 116 26 21
AZITHROMYCIN 122 96 27 43
SERTRALINE HCL 116 95 28 20
FLUTICASONE PROPIONATE 111 92 29 37
FENOFIBRATE 99 80 30 82
TERAZOSIN HCL 94 93 31 77
ALLOPURINOL 88 58 32 26
FOLBIC 79 79 33 294
TAMSULOSIN HCL 78 68 34 29
TRIAMTERENE-HCTZ 71 60 35 36
PRAVASTATIN SODIUM 68 45 36 23
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63 37 67
GLYBURIDE-METFORMIN HCL 63 48 R 37 223
GLIMEPIRIDE 62 54 39 53
PROAIR HFA 56 36 40 41
COLESTIPOL HCL 55 51 41 314
DIOVAN 53 42 42 44
FLUOXETINE HCL 51 37 43 45
AMOX TR-POTASSIUM CLAVULANATE 50 35 44 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.